823 related articles for article (PubMed ID: 33165832)
21. The therapeutic potential of deubiquitinating enzyme inhibitors.
Colland F
Biochem Soc Trans; 2010 Feb; 38(Pt 1):137-43. PubMed ID: 20074048
[TBL] [Abstract][Full Text] [Related]
22. A patent review of the ubiquitin ligase system: 2015-2018.
Li X; Elmira E; Rohondia S; Wang J; Liu J; Dou QP
Expert Opin Ther Pat; 2018 Dec; 28(12):919-937. PubMed ID: 30449221
[TBL] [Abstract][Full Text] [Related]
23. Proteasome deubiquitinases as novel targets for cancer therapy.
D'Arcy P; Linder S
Int J Biochem Cell Biol; 2012 Nov; 44(11):1729-38. PubMed ID: 22819849
[TBL] [Abstract][Full Text] [Related]
24. Novel strategies to target the ubiquitin proteasome system in multiple myeloma.
Lub S; Maes K; Menu E; De Bruyne E; Vanderkerken K; Van Valckenborgh E
Oncotarget; 2016 Feb; 7(6):6521-37. PubMed ID: 26695547
[TBL] [Abstract][Full Text] [Related]
25. Ubiquitin-proteasome system and the role of its inhibitors in cancer therapy.
Aliabadi F; Sohrabi B; Mostafavi E; Pazoki-Toroudi H; Webster TJ
Open Biol; 2021 Apr; 11(4):200390. PubMed ID: 33906413
[TBL] [Abstract][Full Text] [Related]
26. Cullin-RING Ligases as attractive anti-cancer targets.
Zhao Y; Sun Y
Curr Pharm Des; 2013; 19(18):3215-25. PubMed ID: 23151137
[TBL] [Abstract][Full Text] [Related]
27. The Small Molecules Targeting Ubiquitin-Proteasome System for Cancer Therapy.
Ao N; Chen Q; Liu G
Comb Chem High Throughput Screen; 2017; 20(5):403-413. PubMed ID: 28699494
[TBL] [Abstract][Full Text] [Related]
28. The ubiquitin-proteasome system: opportunities for therapeutic intervention in solid tumors.
Johnson DE
Endocr Relat Cancer; 2015 Feb; 22(1):T1-17. PubMed ID: 24659480
[TBL] [Abstract][Full Text] [Related]
29. Ubiquitin Engineering for Interrogating the Ubiquitin-Proteasome System and Novel Therapeutic Strategies.
Tang JQ; Marchand MM; Veggiani G
Cells; 2023 Aug; 12(16):. PubMed ID: 37626927
[TBL] [Abstract][Full Text] [Related]
30. The role of the ubiquitin proteasome system in lymphoma.
Suh KS; Tanaka T; Sarojini S; Nightingale G; Gharbaran R; Pecora A; Goy A
Crit Rev Oncol Hematol; 2013 Sep; 87(3):306-22. PubMed ID: 23541070
[TBL] [Abstract][Full Text] [Related]
31. Patented small molecule inhibitors in the ubiquitin proteasome system.
Guédat P; Colland F
BMC Biochem; 2007 Nov; 8 Suppl 1(Suppl 1):S14. PubMed ID: 18047738
[TBL] [Abstract][Full Text] [Related]
32. Molecular pathways: translational potential of deubiquitinases as drug targets.
D'Arcy P; Linder S
Clin Cancer Res; 2014 Aug; 20(15):3908-14. PubMed ID: 25085788
[TBL] [Abstract][Full Text] [Related]
33. [Ubiquitin-proteasome pathway as a target for therapeutic strategies].
Staszczak M
Postepy Biochem; 2017; 63(4):287-303. PubMed ID: 29374430
[TBL] [Abstract][Full Text] [Related]
34. Proteasome inhibitors.
Cvek B
Prog Mol Biol Transl Sci; 2012; 109():161-226. PubMed ID: 22727422
[TBL] [Abstract][Full Text] [Related]
35. The immunoproteasome as a therapeutic target for hematological malignancies.
Miller Z; Lee W; Kim KB
Curr Cancer Drug Targets; 2014; 14(6):537-48. PubMed ID: 25059201
[TBL] [Abstract][Full Text] [Related]
36. [Research Progress of Ubiquitin Proteasome Inhibitors in Acute Myeloid Leukemia].
Xiao FN; Zhang MY; Zhou Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Oct; 44(5):868-875. PubMed ID: 36325785
[TBL] [Abstract][Full Text] [Related]
37. The ubiquitin-proteasome system (UPS) and the mechanism of action of bortezomib.
Cvek B; Dvorak Z
Curr Pharm Des; 2011; 17(15):1483-99. PubMed ID: 21504411
[TBL] [Abstract][Full Text] [Related]
38. Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance.
Narayanan S; Cai CY; Assaraf YG; Guo HQ; Cui Q; Wei L; Huang JJ; Ashby CR; Chen ZS
Drug Resist Updat; 2020 Jan; 48():100663. PubMed ID: 31785545
[TBL] [Abstract][Full Text] [Related]
39. Deubiquitinases (DUBs) and DUB inhibitors: a patent review.
Farshi P; Deshmukh RR; Nwankwo JO; Arkwright RT; Cvek B; Liu J; Dou QP
Expert Opin Ther Pat; 2015; 25(10):1191-1208. PubMed ID: 26077642
[TBL] [Abstract][Full Text] [Related]
40. Emerging therapies targeting the ubiquitin proteasome system in cancer.
Weathington NM; Mallampalli RK
J Clin Invest; 2014 Jan; 124(1):6-12. PubMed ID: 24382383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
